The Parkinson–Control Study: A 1-Year Randomized, Double-Blind Trial Comparing Piribedil (150 Mg/Day) with Bromocriptine (25 Mg/Day) in Early Combination with Levodopa in Parkinson's Disease
AuthID
P-00G-YYC
P-00G-YYC